Bioline Rx (BLRX)

Add to Watchlists Create an Alert
1.63 -0.05  -2.98%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Bioline Rx Free Cash Flow:

-5.302M for March 31, 2013
View Full Chart

Bioline Rx Free Cash Flow Chart

    Bioline Rx Historical Free Cash Flow Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -5.302M
    Dec. 31, 2012 -6.756M
    Sept. 30, 2012 -4.252M
    June 30, 2012 -5.784M
    March 31, 2012 -3.578M
    Dec. 31, 2011 -4.060M
    Sept. 30, 2011 -1.078M
       
    June 30, 2011 -3.894M
    March 31, 2011 -2.483M
    Dec. 31, 2010
    Sept. 30, 2010 18.11M
    June 30, 2010 -2.262M
    March 31, 2010 -2.905M

    About Free Cash Flow

    Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.

    According to many investors, free cash flow is the best indication of a company's ability to generate cash.
    Learn More

    Get data for

    BLRX Free Cash Flow Benchmarks

    Companies
    Array BioPharma -30.05M
    Cytokinetics -12.40M
    Oramed Pharmaceuticals

    BLRX Free Cash Flow Rankings

    Overall 56th percentile
    3331 of 7600
    Sector 41st percentile
    385 of 653 in Healthcare
    Industry 63rd percentile
    88 of 238 in Biotechnology

    BLRX Free Cash Flow Range, Past 5 Years

    Minimum -6.756M Dec 2012
    Maximum 18.11M Sep 2010
    Average -2.021M